Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net loss	$ (8,390)	$ (105,628)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	17,801	21,719
Amortization of intangible assets	24,501	26,460
Reduction in carrying amount of right-of-use asset	12,129	12,469
Provision for doubtful accounts	270	1,267
Share-based compensation	27,595	26,935
Deferred income taxes	741	1,293
Non-cash restructuring and impairment charges		7,622
Non-cash interest expense	3,195	3,070
Other	2,770	(395)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(8,101)	88,688
Inventories	11,869	16,373
Prepaid expenses and other assets	(7,908)	438
Accounts payable	7,900	(21,530)
Accrued compensation and benefits	351	(24,009)
Operating lease liabilities	(14,983)	(13,222)
Deferred revenue	27,233	43
Other current and long-term liabilities	(9,477)	(14,532)
Net cash provided by operating activities	87,496	27,061
Cash flows from investing activities:
Capital expenditures	(12,318)	(12,630)
Business acquisitions, net of cash acquired		(219,458)
Maturities and sales of investments		45,249
Net cash used in investing activities	(12,318)	(186,839)
Cash flows from financing activities:
Borrowings under Revolving Facility		55,000
Borrowings under Term Loan		199,500
Payments on debt obligations	(69,250)	(29,767)
Loan fees on borrowings		(10,514)
Repurchase of common stock		(30,000)
Proceeds from issuance of common stock, net of tax withholding	7,167	9,491
Payment of contingent consideration obligations	(1,298)	(3,448)
Deferred payments on an acquisition	(3,000)	(3,000)
Net cash (used in) provided by financing activities	(66,381)	187,262
Foreign currency effect on cash	470	(741)
Net increase in cash	9,267	26,743
Cash at beginning of period	193,872	169,607
Cash at end of period	$ 203,139	$ 196,350